InvestorsHub Logo
Followers 69
Posts 7635
Boards Moderated 0
Alias Born 01/10/2014

Re: Investor2014 post# 401483

Sunday, 02/05/2023 10:27:51 AM

Sunday, February 05, 2023 10:27:51 AM

Post# of 464974
Of course "pumpers might believe in their perspective" of a faster approval path and a P4, because it is possible. Just as I can also agree there could be a decision to see an accelerated approval and another P3.

I believe that we will see P3 Precision Medine trials in PD, PDD and likely also AD.



I'm just spitballing here but since S1R modulation is so far upstream in PD, PDD, and AD, couldn't a general "dementia" trial be created? Or am I naive to think it could deviate from indication specific trials as currently done?

And to be more specific, being precision medicine, what biomarkers would be used to improve outcomes?
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News